Sector Update: Health Care Stocks Retreating Late Afternoon

Health care stocks eased in late Wednesday afternoon trading, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each decreasing 0.1%. The iShares Biotechnology ETF (IBB

MT NewswiresApr 18 03:53

Sector Update: Health Care

Health care stocks ease in late Wednesday afternoon trading with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) both decreasing 0.1%. The iShares Biotechnology ETF (IBB)

MT NewswiresApr 18 03:32

Connect Biopharma Terminates Agreement on Antiallergic Candidate With Pfizer

Connect Biopharma (CNTB) is terminating its in-license agreement for CBP-174, an antiallergic, with Pfizer (PFE), effective May, to optimize resources and extend its cash runway The company said Tuesd

MT NewswiresApr 18 02:48

Connect Biopharma Is Maintained at Buy by HC Wainwright & Co.

Connect Biopharma Is Maintained at Buy by HC Wainwright & Co.

Dow JonesApr 17 18:50

HC Wainwright & Co. : The rating of Conrad Biopharmaceuticals (CNTB.US) was maintained, adjusted from buy to buy rating, and the target price was adjusted from $7.00 to $8.00.

HC Wainwright & Co. : The rating of Conrad Biopharmaceuticals (CNTB.US) was maintained, adjusted from buy to buy rating, and the target price was adjusted from $7.00 to $8.00.

Zhitong FinanceApr 17 18:40

HC Wainwright & Co. Maintains Buy on Connect Biopharma Hldgs, Raises Price Target to $8

HC Wainwright & Co. analyst Emily Bodnar maintains Connect Biopharma Hldgs (NASDAQ:CNTB) with a Buy and raises the price target from $7 to $8.

BenzingaApr 17 18:40